Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Mylan First Quarter Profit Jumps on Sales of Generic Drugs

By Pharmaceutical Processing | May 3, 2011

PITTSBURGH (AP) — Generic drug maker Mylan Inc. said today
that its first-quarter profit rose 71 percent, mainly on increasing drug sales
in North America.

The company earned $104.2 million, or 23 cents per share,
for the three months ended March 31, up from $61.1 million, or 20 cents per
share, a year ago. The most recent quarter included an additional 136.5 million
shares of stock outstanding.

Revenue rose 12 percent to $1.45 billion.

Excluding charges, including purchase accounting items and
litigation expenses, the company said it earned 44 cents per share, matching
expectations of analysts polled by FactSet. Analysts expected revenue of about
$1.43 billion.

Generic drug revenue rose 12 percent to $1.34 billion during
the quarter, driven by volume in North America.
Specialty drug revenue rose 17 percent to $97 million.

Looking ahead, the company reaffirmed 2011 profit guidance
between $1.90 and $2.10 per share. In February, the company also said it
expects revenue between $6.1 billion and $6.4 billion. Analysts expect profit
of about $2.01 per share on revenue of about $6.1 billion

Also, Mylan said its board of directors approved a $350
million stock buyback program, which is expected to be completed by June 30.

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards